RxDoctor Payments Data

Thea Heaton, PA

Physician Assistant · Nampa, IDNPI 1811998628

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,617 of the $6,191 with a category attached, or 74.6%. 19 manufacturers reported payments, led by Johnson & Johnson at 32.9% of the total. Reporting peaked in 2024 at $2,480 and has fallen 55.1% since, to $1,114 in 2025. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,191in general payments, 2019–2025

Across 209 payments — averaging $29.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$2K
  • E.r. Squibb & Sons, L.L.C.$469
  • UCB, Inc.$278
  • Incyte Corporation$263
  • Regeneron Healthcare Solutions, Inc.$225
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$1,06317%
  • Food & beverage$4,61775%
  • Education$5128%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,191 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$75,176
Medicare patients
351
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab13$84,142
Clobetasol Propionate95$2,631
Doxycycline Hyclate43$1,977
Acitretin11$1,821
Betamethasone Dipropionate39$1,440
Ketoconazole119$1,395
Fluocinonide26$1,146
ValacyclovirValacyclovir Hcl18$1,119
Hydroxychloroquine Sulfate18$749
Metronidazole11$657
Ciclopirox20$557
Mycophenolate Mofetil14$425
Cephalexin32$275
Nystatin22$201
Triamcinolone Acetonide36$191

Paid to pharmacies, not to this prescriber.

Other physician assistant in Nampa

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →